CardioKinetix
DefunctMenlo Park, US · 5 known investors
Find your way into CardioKinetix
CardioKinetix developed the Parachute Ventricular Partitioning Device, a catheter-based implant that partitions the left ventricle to help restore cardiac function after heart attacks.
Founders & leadership
BH
Brett HaleExecutive
MS

Maria SainzExecutive
Board
LB
Lou BockBoard director
JD
CT
Casey TanseyBoard director
RF
Rodney FergusonBoard director
PL
Paul LaVioletteBoard director
FG
Frank GentileBoard director
EF
Eric FainBoard director
Investors · 5
Archer Capital Grouplisted by Archer Capital GroupLos Angeles
How we know: Archer Capital Group's portfolio page · Not right? Tell us
Archer Venture Capitallisted by Archer Venture CapitalLos Angeles
How we know: Archer Venture Capital's portfolio page · Not right? Tell us
SV Health Investorslisted by SV Health InvestorsLondon · $1M – $20M
How we know: SV Health Investors's portfolio page · a partner's Signal profile · Not right? Tell us
New Leaf Venture PartnersreportedNew York
How we know: funding news · Not right? Tell us
SV Life SciencesreportedBoston
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30.7M disclosed across 1 round · 2014
▶$30.7MraisedDec 2014 · 12 investors · Other Health CareRule 506(b)
▶$30.7MraisedDec 2014 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lou BockDirector
- Brett HaleExecutive Officer
- Jeani DelagardelleDirector
- Casey TanseyDirector
- Frank GentileDirector
- Maria SainzExecutive Officer, Director
- Eric FainDirector
- Rodney FergusonDirector
- Paul LaVioletteDirector
- Offering amount
- $37.7M
- Amount sold
- $30.7M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does CardioKinetix do?
- CardioKinetix developed the Parachute Ventricular Partitioning Device, a catheter-based implant that partitions the left ventricle to help restore cardiac function after heart attacks.
- Who are CardioKinetix's investors?
- CardioKinetix's investors include Archer Capital Group, Archer Venture Capital, SV Health Investors, New Leaf Venture Partners, SV Life Sciences.
- How much funding has CardioKinetix raised?
- CardioKinetix has disclosed $30.7M raised across 1 round.
- Where is CardioKinetix headquartered?
- CardioKinetix is headquartered in Menlo Park, US.

